Approval · Notice of Compliance 19486 · 2017
CIMZIA: Notice of Compliance 19486
Issued July 4, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19486
- Date
- July 4, 2017
- Company
- Ucb Canada IncOakville, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a new secondary container closure system;
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CIMZIA | Not yet assigned | — |
Medicinal ingredients
- CERTOLIZUMAB PEGOL 200 MG per ML